Emerging strategies for prospective discovery of molecular glue degraders
Authors:
- 9 April 2024
- journal article
- research article
- Published by Elsevier in Current Opinion in Structural Biology
- Vol. 86, 102811
Abstract
No abstract availableKeywords
Funding Information
- Howard Hughes Medical Institute
- University of Washington
This publication has 58 references indexed in Scilit:
- Dual IKZF2 and CK1α degrader targets acute myeloid leukemia cellsCancer Cell, 2023
- Chemoproteomics-enabled discovery of a covalent molecular glue degrader targeting NF-κBCell Chemical Biology, 2023
- Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapyCell Chemical Biology, 2023
- E3 ubiquitin ligase ASB8 promotes selinexor-induced proteasomal degradation of XPO1Biomedicine & Pharmacotherapy, 2023
- KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potentialMedicinal Research Reviews, 2022
- An E3 ligase guide to the galaxy of small-molecule-induced protein degradationCell Chemical Biology, 2021
- The Rise of Molecular GluesCell, 2021
- Aryl Sulfonamides Degrade RBM39 and RBM23 by Recruitment to CRL4-DCAF15Cell Reports, 2019
- Structural Basis and Kinetic Pathway of RBM39 Recruitment to DCAF15 by a Sulfonamide Molecular Glue E7820Structure, 2019
- The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53Cell, 1990